scispace - formally typeset
R

Richard M. Epand

Researcher at McMaster University

Publications -  521
Citations -  26937

Richard M. Epand is an academic researcher from McMaster University. The author has contributed to research in topics: Membrane & Peptide. The author has an hindex of 80, co-authored 515 publications receiving 25125 citations. Previous affiliations of Richard M. Epand include Brigham Young University & University of Edinburgh.

Papers
More filters
Journal ArticleDOI

Substrate specificity of diacylglycerol kinase-epsilon and the phosphatidylinositol cycle.

TL;DR: It is suggested that in addition to binding to the enzyme, the acyl chain at the sn‐1 position may contribute to the depth of insertion of the DAG into the membrane.
Journal ArticleDOI

On the mechanism of inhibition of viral and vesicle membrane fusion by carbobenzoxy-D-phenylalanyl-L-phenylalanylglycine

TL;DR: Differential scanning calorimetry, 2H nuclear magnetic resonance (NMR), and 13C NMR of phosphatidylcholine bilayers in the presence of Z-D-P he-L-PheGly indicate that this hydrophobic peptide penetrates the phospholipid bilayer but does not strongly perturb the properties of phosph atidyl choline bilayer with a large effective radius of curvature.
Journal ArticleDOI

Role of chirality in peptide-induced formation of cholesterol-rich domains

TL;DR: It is determined that replacing cholesterol with its enantiomer, ent-cholesterol, alters the modulation of lipid organization by peptides, and a specific chirality of membrane lipids is required for peptide-induced formation of cholesterol-rich domains.
Journal ArticleDOI

Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice

TL;DR: It is shown that Ac-hE18A-NH2, a dual-domain cationic apolipoprotein-mimetic peptide, reduces plasma cholesterol levels in dyslipidemic mice and has stronger interactions with lipids than did m18L.
Journal ArticleDOI

Structural requirements for the inhibition of membrane fusion by carbobenzoxy-d-Phe-Phe-Gly

TL;DR: The results demonstrate that having the carbobenzoxy group on the amino-terminus of fFG is important for giving the peptide derivative the property of inhibiting membrane fusion.